ICIG adds two more European sites

Article Abstract:

Private investment company International Chemical Investors Group (ICIG) has bought two new European sites to add to its growing portfolio of medium-sized chemical businesses. ICIG has bought Synkem from Solvay and an AstraZeneca site in Germany. ICIG's track record of acquisition deals are also discussed.

Facilities & equipment, United Kingdom, Belgium, Buildings and facilities, AstraZeneca PLC, AZN, Solvay S.A. (Brussels, Belgium)

---

Lonza continues global biotech drive

Article Abstract:

The acquisition of the biopharma and bioproducts business of Cambrex Corp. by Lonza is described. The proposed merger of the microbial biopharmaceutical activities of Lonza at the former Cambrex facility in Hopkinton, Massachusetts, is discussed.

Organizational history, Drugs, United States, Biotechnology industry, Biotechnology industries, Company restructuring/company reorganization, Reorganization and restructuring, Company organization, Lonza Group Ltd., Cambrex Bio Science, Cambrex Biopharmaceutical Services

---

Archimica reborn

Article Abstract:

The reasons for the choice of Archimica as the name for United Kingdom-based private equity firm TowerBrook Capital Partners 's newly acquired Pharmaceutical Fine Chemicals (PFC) unit are discussed. PFC is a unit of Clariant.

Germany, Organizational nomenclature, Names, Clariant AG, Branches (Business enterprises)

Similar abstracts:

• Abstracts: One- and two-color photon echo peak shift studies of photosystem I. Exciton binding energy in semiconducting single-walled carbon nanotubes
• Abstracts: Industry trends. How to analyze a chemical company
• Abstracts: REACH fees head north again. US states act against deca-BDE. Registering chemicals in China

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.